Abstract
We have developed a drug-loaded, pH-sensitive, nano-magnetic targeted system (DPNTS) for delivering doxorubicin (DOX) to tumor tissues through a facile route. Iron oxide (Fe3O4) nanoparticles were used as magnetically-responsive carriers, polyethyleneglycol (PEG) as the surface-modifying agent, and polyethyleneimine (PEI) as the drug-loading site whose primary amine reacts with the 13-carbonyl of DOX. The prepared DPNTS was within 20 nm and had good stability in dispersion and superparamagnetic properties. DOX was grafted to PEG/PEI@Fe3O4 at up to 85 %. During in vitro release studies, nearly 81 % DOX was released from DPNTS within 72 h at pH 4.5, compared with only 28 % at pH 7.4.
Similar content being viewed by others
References
Alakhov V, Klinski E, Li SM, Pietrzynski G, Venne A, Batrakova E, Bronitch T, Kabanov A (1999) Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloid Surf B 16:113–134
Banerjee S, Sen K, Pal TK, Guha SK (2012) Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy. Int J Pharm 436:786–797
Cheng R, Meng FH, Deng C, Klok HA, Zhong ZY (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34:3647–3657
Dai JJ, Wu SX, Jiang W, Li PY, Chen XL, Liu L, Liu J, Sun DP, Chen W, Chen BH (2013) Facile synthesis of pectin coated Fe3O4 nanospheres by the sonochemical method. J Magn Magn Mater 331:62–66
Gerweck LE, Seetharaman K (1996) Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 56:1194–1198
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021
Han T, Das DB (2013) Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles. J Pharm Sci 102:3614–3622
Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V (2005) Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm 2:194–205
Kim JO, Kabanov AV, Bronich TK (2009) Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin. J Control Release 138:197–204
Nayak A, Das DB (2013) Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine. Biotechnol Lett 35:1351–1363
Tewes F, Ehrhardt C, Healy AM (2014) Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung. Eur J Pharm Biopharm 86:98–104
Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, Chen Y (2008) High-efficiency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C 112:17554–17558
Zhang DW, Das DB, Rielly CD (2013a) Potential of microneedle assisted micro-particle delivery by gene guns: a review. Drug Deliv 0:1–17
Zhang BL, Tu ZJ, Zhao FY, Wang J (2013b) Superparamagnetic iron oxide nanoparticles prepared by using an improved polyol method. Appl Surf Sci 266:375–379
Zhang DW, Das DB, Rielly CD (2014) Microneedles assisted micro-particles delivery from gene guns: experiments using skin mimicking agarose gel. J Pharm Sci 103:613–627
Zhu SJ, Hong MH, Zhang LH, Tang GT, Jiang YY, Pei YY (2010) PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation. Pharm Res 27:161–174
Acknowledgments
The authors are grateful for support from the National Science Foundation of China (Project No. 50602024, No.50972060), the Scientific and Technical Supporting Programs of Jiangsu province (BE2012758), the Scientific Research Fund from NJUST Research Funding (No.2010ZDJH06), and the Fundamental Research Funds for the Central Universities (No.30920130112003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, J., Xu, S., Jiang, W. et al. Facile preparation of a pH-sensitive nano-magnetic targeted system to deliver doxorubicin to tumor tissues. Biotechnol Lett 37, 585–591 (2015). https://doi.org/10.1007/s10529-014-1708-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-014-1708-x